Literature DB >> 7109101

Long-term results with the Kaufman prosthesis.

S D Graham, C C Carson, E E Anderson.   

Abstract

Patients with incontinence after prostatectomy were examined for long-term results following implantation of a Kaufman prosthesis. These appears to be a dichotomy between patients who underwent implantations of the device after radical procedures versus those who had been operated upon for benign disease. Patients undergoing implantation of the prosthesis after an operation for malignant disease experienced a higher rate of complications and a lower over-all continence rate. Also, patients who underwent implantation of the Kaufman prosthesis in conjunction with the Small-Carrion prosthesis showed a 100 per cent failure rate. It appears from the data that the Kaufman prosthesis is not the long sought panacea.

Entities:  

Mesh:

Year:  1982        PMID: 7109101     DOI: 10.1016/s0022-5347(17)52911-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

Review 1.  Combination surgery for erectile dysfunction and male incontinence.

Authors:  Dominic Lee; O Lenaine Westney; Run Wang
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 2.  Simultaneous penile prosthesis and male sling/artificial urinary sphincter.

Authors:  Dominic Lee; Claudio Romero; Frances Alba; O Lenaine Westney; Run Wang
Journal:  Asian J Androl       Date:  2012-12-03       Impact factor: 3.285

3.  Artificial urinary sphincters.

Authors:  R H Whitaker
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-29

Review 4.  Dual implantation of penile and sphincter implants in the post-prostatectomy patient.

Authors:  Rajeev Kumar; Ajay Nehra
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

Review 5.  Artificial urinary sphincter: current status and future directions.

Authors:  Culley C Carson
Journal:  Asian J Androl       Date:  2020 Mar-Apr       Impact factor: 3.285

Review 6.  Targeting neoantigens for cancer immunotherapy.

Authors:  Xuan Zhao; Xiaoxin Pan; Yi Wang; Yi Zhang
Journal:  Biomark Res       Date:  2021-07-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.